Nuvation Bio Inc. — Director's Dealing 2022

Jul 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nuvation Bio Inc. (NUVB)
CIK: 0001811063
Period of Report: 2022-07-15

Reporting Person: Liu Dongfang (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-07-15	Stock Option (Right to Buy)	$3.61	A	490000	Acquired	2032-07-14	Common Stock (490000)	Direct
2022-07-15	Stock Option (Right to Buy)	$3.61	A	292500	Acquired	2032-07-14	Common Stock (292500)	Direct

Footnotes

F1: Option vests as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.

F2: The shares subject to the Options will vest based on the satisfaction of both time-based and performance-based vesting criteria.